Nagao S - Search Results

1

Determinants of drug response in camptothecin-11-resistant glioma cell lines.

Matsumoto Y, Fujiwara T, Nagao S. Matsumoto Y, et al. Among authors: nagao s. J Neurooncol. 1995;23(1):1-8. doi: 10.1007/BF01058453. J Neurooncol. 1995. PMID: 7623066

2

Intraoperative radiotherapy for gliomas.

Fujiwara T, Honma Y, Ogawa T, Irie K, Kuyama H, Nagao S, Takashima H, Hosokawa A, Ohkawa M, Tanabe M. Fujiwara T, et al. Among authors: nagao s. J Neurooncol. 1995;23(1):81-6. doi: 10.1007/BF01058463. J Neurooncol. 1995. PMID: 7623073 Clinical Trial.

3

[Quantitative analysis of DNA topoisomerase I activity in human and rat glioma: characterization and mechanism of resistance to antitopoisomerase chemical, camptothecin-11].

Matsumoto Y, Fujiwara T, Honjo Y, Sasaoka N, Tsuchida T, Nagao S. Matsumoto Y, et al. Among authors: nagao s. Noshuyo Byori. 1994;11(1):59-64. Noshuyo Byori. 1994. PMID: 8162152 Japanese.

4

Quantitative analysis of DNA topoisomerase I activity in human and rat glioma: characterization and mechanism of resistance to antitopoisomerase chemical, camptothecin-11.

Matsumoto Y, Fujiwara T, Honjo Y, Sasaoka N, Tsuchida T, Nagao S. Matsumoto Y, et al. Among authors: nagao s. J Surg Oncol. 1993 Jun;53(2):97-103. doi: 10.1002/jso.2930530210. J Surg Oncol. 1993. PMID: 8388965

5

[Expression of ATP binding cassette superfamily (multidrug resistance-1, multidrug resistance-associated protein, human canalicular multispecific organ anion transporter) mRNA in etoposide and m-AMSA resistant cell lines].

Matsumoto Y, Matsumoto M, Minemura M, Takano H, Nagao S, Iglesias A, Fojo T. Matsumoto Y, et al. Among authors: nagao s. Gan To Kagaku Ryoho. 1997 Oct;24(13):1941-6. Gan To Kagaku Ryoho. 1997. PMID: 9350240 Japanese.

6

[Expression of DNA topoisomerases (I, II alpha, II beta) mRNA in etoposide- and mAMSA-resistant cell lines].

Matsumoto Y, Takano H, Nagao S, Iglesias A, Fojo T. Matsumoto Y, et al. Among authors: nagao s. Gan To Kagaku Ryoho. 1997 Dec;24(15):2265-9. Gan To Kagaku Ryoho. 1997. PMID: 9422071 Japanese.

7

[Incidence of mutation and deletion in topoisomerase II mRNA of etoposide and m-AMSA resistant cell lines].

Matsumoto Y, Morisaki K, Kunishio K, Nagao S, Takano H, Fojo T. Matsumoto Y, et al. Among authors: nagao s. Gan To Kagaku Ryoho. 1998 Jul;25(8):1145-9. Gan To Kagaku Ryoho. 1998. PMID: 9679576 Japanese.

8

Increased phosphorylation of DNA topoisomerase II in etoposide resistant mutants of human glioma cell line.

Matsumoto Y, Kunishio K, Nagao S. Matsumoto Y, et al. Among authors: nagao s. J Neurooncol. 1999;45(1):37-46. doi: 10.1023/a:1006346624083. J Neurooncol. 1999. PMID: 10728908

9

Hypophosphorylation of topoisomerase IIalpha in etoposide (VP-16)-resistant human carcinoma cell lines associated with carboxy-terminal truncation.

Matsumoto Y, Takano H, Kunishio K, Nagao S, Fojo T. Matsumoto Y, et al. Among authors: nagao s. Jpn J Cancer Res. 2001 Jul;92(7):799-805. doi: 10.1111/j.1349-7006.2001.tb01164.x. Jpn J Cancer Res. 2001. PMID: 11473732 Free PMC article.

10

Altered topoisomerase IIalpha and multidrug resistance-associated protein levels during drug selection: adaptations to increasing drug pressure.

Matsumoto Y, Takano H, Nagao S, Fojo T. Matsumoto Y, et al. Among authors: nagao s. Jpn J Cancer Res. 2001 Sep;92(9):968-74. Jpn J Cancer Res. 2001. PMID: 11572765

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,140 results

Search Page

Filters